FDA & Health Canada Emergency Use Authorized

Easy To Use Portable Point Of Care Rapid Test instrument

The Most Widely Available Rapid Point Of Care Test Across The USA & Canada

ID NOW is one of the most widely-available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians’ offices and urgent care centers to rapidly detect influenzas A & B, strep A, and respiratory syncytial virus (RSV). When faced with the threat of novel coronavirus, our scientists mobilized to quickly bring a new COVID-19 detection test to the fight against this deadly virus.

ID NOW is an FDA approved CLIA-waived instrument, which means that the technology can be used in settings outside the traditional hospital setting.

To conduct a test, a swab of the nose is taken. Then the swab is placed into an acidic liquid solution heated to 132.8⁰ F that cracks open the envelope of the SARS-CoV-2 virus, exposing its viral RNA.

Then the small device, about the size of a toaster and weighing only 6.6 pounds, amplifies the RNA hundreds of millions of times to make the virus detectable — returning test results in 13 minutes or less.